Life-threatening gastrointestinal bleeding related to the treatment of strongyloidiasis hiperinfection in an immunecompromised patient;Életet veszélyezteto gastrointestinalis vérzés strongyloides hiperinfekció kezelése kapcsán immunszupprimált betegben

Orvosi Hetilap

Volumn 145, Issue 4, 2004, Pages 181-185

  Jaafar, Hassan ^a,b   Kristensen, Jorgen ^a,b   Zwaan, Ferdinand ^a,b   Castella, Antonio ^a,b   Gorka, Waldemar ^a,b   Berry, Lindsey ^a,b   Alizadeh, Hussain ^d   Trab, Fawaz ^c   Branicki, Frank ^c   Hunyady, Béla ^d,e  

^a TAWAM HOSPITAL   (United Arab Emirates)

^b Egyesült Arab Emirátusok   (United Arab Emirates)

^c UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^d UNIVERSITY OF PÉCS   (Hungary)

^e NONE   (Hungary)

Author keywords

Exsudative enteropathy; Gastrointestinal bleeding; Immunosuppression; Myeloma; Strongyloides stercoralis; Vasculitis

Indexed keywords

ALBENDAZOLE; RECOMBINANT BLOOD CLOTTING FACTOR 8; ANTHELMINTIC AGENT; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CHEMOTHERAPY; ENDOSCOPY; FECES ANALYSIS; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS; HUMAN; IMMUNE DEFICIENCY; INTESTINE BIOPSY; MALE; MICROANEURYSM; MULTIPLE MYELOMA; STEROID THERAPY; STRONGYLOIDIASIS; VASCULITIS; ANIMAL; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; MIDDLE AGED; PARASITOLOGY; STRONGYLOIDES STERCORALIS;

ANIMALS; ANTHELMINTICS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; GASTROINTESTINAL HEMORRHAGE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MULTIPLE MYELOMA; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 1642340740     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Armstrong, J. és Cohen, J.: Infectious Diseases., Blackwell Science, London, 1999, 2, 37-3. old.
2. Barlogie, B., Smith, L., Alexanian, R.: Effective treatment of advanced multiple myeloma refractory to alkylating agents. N. Engl. J. Med., 1984, 310, 1353-1356.
3. Hughes, R. és McGuire, G.: Delayed diagnosis of disseminated strongyloidiasis. Intensive Care Med., 2001, 27, 310-312.
4. Mineur, P., Menard, J. F., Le, L. X. és mtsai: VAD or VMBCP in Multiple myeloma refractory to or relapsing after cyclophosphamide-prednisone therapy (Protocol MY 85). Br. J. Haematol., 1998, 103, 512-517.
5. Reiman, S., Fisher, R., Dodds, C. és mtsai: Mesenteric Arteriographic findings in a patient with strongyloides stercoralis hyperinfection. J. Vasc. Interv. Radiol., 2002, 13, 635-638.
6. Strickland, G. T.: Hunter's tropical medicine and emerging infectious diseases. Lippincott, Philadelphia 2000.
7. Suvajdzic, N., Kranjcic-Zec, I., Jovanovic, V. és mtsai: Fatal strongyloidiasis following corticosteroid therapy in a patient with chronic idiopathic thrombocytopenia. Haematologia (Budap.), 1999, 29, 323-326.
8. Thomas, M. C. és Costello, S. A. Disseminated strongyloidiasis arising from a single dose of dexamethasone before stereotactic radiosurgery. Int. J. Clin. Pract., 1998, 52, 520-521.